Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study

Background & aimsThis multicenter retrospective study evaluated the efficacy and safety of transarterial chemoembolization (TACE) combined with donafenib and a programmed death-1 (PD-1) inhibitor (TACE+DP) and TACE combined with donafenib (TACE+D) for unresectable hepatocellular carcinoma (uHCC)...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hao Li, Jiacheng Wang, Guokun Zhang, Donglin Kuang, Yanliang Li, Xiang He, Cheng Xing, Yong Wang, Ming Shi, Xinwei Han, Jianzhuang Ren, Xuhua Duan
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2023-11-01
Saila:	Frontiers in Immunology
Gaiak:	donafenib programmed death-1 inhibitors transarterial chemoembolization unresectable hepatocellular carcinoma multicenter retrospective study
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1277329/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!